Skip to content

SONDA-EMP in ABI

Screening for visual function loss from acquired brain injury with SONDA-based eye movement perimetry - Screening for visual function loss from acquired brain injury with SONDA- based eye movement perimetry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58499
Enrollment
104
Registered
2025-12-18
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual field defects The visual field is everything a person can see when fixating on a point in space.

Interventions

No therapeutic intervention is involved. Each participant will undergo SAP (gold standard) once as part of standard regular care. For SAP in this specific population, we use a binocular Esterman test.
Directly hereafter, the participant will perform SONDA-EMP once per eye, preceded by a short test-run to get acquainted with the test. SAP is part of standard regular care.In patients without prior ex
For patients with known visual field defects who are familiar with SAP (e.g. patients with glaucoma), SAP will not be repeated provided the test is deemed reliable, in line with standard clinical care
Data analysis of SONDA-EMP will be conducted after the study session
therefore, the results will not be accessible to the performing optometrist during the assessment.&nbsp

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ABI patient with VF loss: -    Diagnosed with ABI, and VF defects on SAP  -    Visual Acuity (best corrected) 0.3 logMAR (or better) -    Age: 18-80 -    Informed written consentABI patient with VF loss: -    Diagnosed with ABI, and without VF defects on SAP  -    Visual Acuity (best corrected) 0.3 logMAR (or better) -    Age: 18-80 -    Informed written consent  

Exclusion criteria

Exclusion criteria: Severe cognitive, motor, or language impairments that prevent correct test execution. Visual acuity worse than 0.3 logMAR (corrected). Unreliable SAP-measurement upon repeat testing  

Design outcomes

Primary

MeasureTime frame
The screening performance: AUC and the sensitivity at 95% specificityThe output of the feedback questionnaire for SONDA-EMP compared to SAP.

Countries

Netherlands

Contacts

Public ContactA.C.L. Vrijling

Universitair Medisch Centrum Groningen

annevrijling@visio.org0885855700

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026